{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:48:40Z","timestamp":1783608520298,"version":"3.55.0"},"reference-count":21,"publisher":"Akademiai Kiado Zrt.","issue":"9","license":[{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2022,2,27]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic> A SARS-CoV-2-fert\u0151z\u00e9s elh\u00faz\u00f3d\u00f3 t\u00fcneteit 4 h\u00e9ten t\u00fal\n                    poszt-COVID\u201319-t\u00fcneteknek nevezz\u00fck, \u00e9s fenn\u00e1ll\u00e1si id\u0151 szerint csoportos\u00edtjuk.\n                        <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic> A vizsg\u00e1lat c\u00e9lja egy h\u00e1ziorvosi k\u00f6rzet\n                    megk\u00f6zel\u00edt\u0151leg \u00e1lland\u00f3 popul\u00e1ci\u00f3j\u00e1ban megfigyelni, hogy adott id\u0151intervallumon\n                    bel\u00fcl a SARS-CoV-2-fert\u0151z\u00f6ttek k\u00f6z\u00f6tt milyen ar\u00e1nyban, milyen jelleg\u0171\n                    poszt-COVID\u201319-t\u00fcnetek alakulnak ki, \u00e9s mennyi ideig tartanak.\n                        <jats:italic>M\u00f3dszer:<\/jats:italic> 282 SARS-CoV-2-beteg t\u00fcneteit 2020. szeptember 1.\n                    \u00e9s 2021. szeptember 1. k\u00f6z\u00f6tt k\u00f6vett\u00fck, 4 hetente, 15\u201342 h\u00e9ten \u00e1t \u2013 elh\u00faz\u00f3d\u00f3\n                    szagl\u00e1szavar eset\u00e9n 30\u201350 h\u00e9ten \u00e1t \u2013, els\u0151sorban telefonos interj\u00fak\n                    seg\u00edts\u00e9g\u00e9vel. <jats:italic>Eredm\u00e9nyek:<\/jats:italic> Egy h\u00f3napon t\u00fali panaszok a betegek\n                    67%-\u00e1ban (170 f\u0151) alakultak ki. A leggyakoribb t\u00fcnet a f\u00e1rad\u00e9konys\u00e1g (79 f\u0151,\n                    29%) \u00e9s a szagl\u00e1szavar volt (74 f\u0151, 27%). Az ut\u00f3bbi jellemz\u0151en nem doh\u00e1nyz\u00f3k\n                    k\u00f6r\u00e9ben l\u00e9pett fel, \u00e9s a COVID\u201319-fert\u0151z\u00f6ttek 2,5%-\u00e1ban 43 h\u00e9ten t\u00fal is\n                    fennmaradt. A f\u00e1rad\u00e9konys\u00e1g panaszk\u00f6re a poszt-COVID\u201319-betegek 46%-\u00e1t\n                    \u00e9rintette. Ezen betegek szignifik\u00e1nsan hosszabb id\u0151t t\u00f6lt\u00f6ttek\n                    keres\u0151k\u00e9ptelens\u00e9gi \u00e1llom\u00e1nyban, mint azok, akik nem voltak f\u00e1rad\u00e9konyak (12,3\n                        <jats:italic>vs.<\/jats:italic> 19,7 nap). Az enyhe SARS-CoV-2-fert\u0151z\u00e9st k\u00f6vet\u0151 s\u00falyos\n                    f\u00e1rad\u00e9konys\u00e1ggal k\u00fczd\u0151 betegek a panaszaikat szindr\u00f3maszer\u0171en \u00edrt\u00e1k le, melyre\n                    jellemz\u0151 volt a palpit\u00e1ci\u00f3, a f\u00e1rad\u00e9konys\u00e1g, a terhel\u00e9sre jelentkez\u0151 l\u00e9gszomj,\n                    az alv\u00e1szavar, a laza sz\u00e9klet \u00e9s a posturalis panaszok. Ezek \u00e1tlagosan 19 h\u00e9t\n                    alatt m\u00faltak el. <jats:italic>Megbesz\u00e9l\u00e9s:<\/jats:italic> A poszt-COVID\u201319-t\u00fcnetek\n                    kialakul\u00e1sa enyhe lefoly\u00e1s mellett is gyakori, a lefoly\u00e1s s\u00falyoss\u00e1ga sok esetben\n                    nincs ar\u00e1nyban a poszt-COVID\u201319-f\u00e1rad\u00e9konys\u00e1g s\u00falyoss\u00e1g\u00e1val. A\n                    posztakut-COVID\u201319-f\u00e1rad\u00e9kony betegek k\u00f3rh\u00e1zi kezel\u00e9st nem ig\u00e9nyl\u0151 csoportja\n                    sz\u00e1mos t\u00e9nyez\u0151 alapj\u00e1n elk\u00fcl\u00f6n\u00edthet\u0151 a posztakut-COVID\u201319-f\u00e1rad\u00e9kony betegek\n                    hospitaliz\u00e1lt csoportj\u00e1t\u00f3l. <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic> Az enyhe\n                    COVID\u201319-fert\u0151z\u00e9st is k\u00f6vetheti elh\u00faz\u00f3d\u00f3 f\u00e1rad\u00e9konys\u00e1g poszt-COVID\u201319-t\u00fcnetk\u00e9nt,\n                    mely spont\u00e1n regredi\u00e1l. SARS-CoV-2-fert\u0151z\u00e9st k\u00f6vet\u0151en hossz\u00fa t\u00e1von fennmaradhat\n                    szagl\u00e1szavar, illetve a k\u00f6z\u00e9ps\u00falyos \u00e9s s\u00falyos COVID\u201319-eseteket k\u00f6vet\u0151en\n                    f\u00e1rad\u00e9konys\u00e1g. Orv Hetil. 2022; 163(9): 335\u2013342.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold>\n                    <jats:italic>Introduction:<\/jats:italic> Extended symptoms may develop after a SARS-CoV-2\n                    infection. We refer to these as post-COVID\u201319 symptoms and they are grouped\n                    according to time duration. <jats:italic>Objective:<\/jats:italic> The aim of the study was\n                    to follow all COVID\u201319 infected patients in a family practise, to observe all\n                    post-COVID\u201319 symptoms, symptom development rates and to document how long they\n                    last. <jats:italic>Method:<\/jats:italic> 282 SARS-CoV-2 patients were followed mainly\n                    through telephone interviews between 01. 09. 2020 and 01. 09. 2021.\n                    Post-COVID\u201319 symptoms were monitored for 15\u201342 weeks every 4 weeks (30\u201350 weeks\n                    in cases of delayed hypsomia). <jats:italic>Results:<\/jats:italic> Symptoms lasting longer\n                    than a month developed in 67% of all patients (170 cases). The most frequent\n                    symptoms were fatigue (79 cases, 29%) and hyposmia (74 cases, 27%). The latter\n                    mainly developed in non-smokers, affecting 2,5% of all COVID\u201319 patients beyond\n                    43 weeks. Fatigue affected 46% of all post-COVID\u201319 patients. Sick leave was\n                    significantly longer among these patients (19.7 <jats:italic>vs.<\/jats:italic> 12.3 days\n                    in patients with no fatigue). Severe post-COVID\u201319 fatigue in non-hospitalized\n                    patients presented in a sydrome-like appearance displaying palpitations,\n                    fatigue, dyspnoea, sleep disturbances, loose stools and postural complaints.\n                    These regrediated after 19 weeks. <jats:italic>Discussion:<\/jats:italic> Post-COVID\u201319\n                    symptoms often develop after a mild COVID\u201319 infection. Severity of COVID\u201319\n                    infection and severity of post-COVID\u201319 symptoms often do not correlate. Groups\n                    of hospitalized and non-hospitalized post-acute COVID patients with fatigue can\n                    be distinguished by many attributes. <jats:italic>Conclusion:<\/jats:italic> Mild COVID\u201319\n                    infections may also be followed up by severe fatigue, but it spontenaously\n                    regrediates. Long-term effects of COVID\u201319 are permanent hyposmia and fatigue\n                    (the latter affect some hospitalized COVID\u201319 patients). Orv Hetil. 2022;\n                    163(9): 335\u2013342.<\/jats:p>","DOI":"10.1556\/650.2022.32432","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T17:51:58Z","timestamp":1668793918000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":9,"title":["Poszt-COVID\u201319-szindr\u00f3m\u00e1s esetek kialakul\u00e1s\u00e1nak k\u00f6vet\u00e9se"],"prefix":"10.1556","volume":"163","author":[{"given":"J\u00f3zsef","family":"Tamasi","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Csal\u00e1dorvosi Tansz\u00e9k Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Kalabay","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Csal\u00e1dorvosi Tansz\u00e9k Budapest Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Fekete M, Szarvas Z, Fazekas-Pongor V, et al. Outpatient rehabilitation programs for COVID-19 patients. [Ambul\u00e1ns rehabilit\u00e1ci\u00f3s programok COVID-19-betegek sz\u00e1m\u00e1ra.] Orv Hetil. 2021; 162: 1671-1677. [Hungarian]","DOI":"10.1556\/650.2021.32332"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2 Szekanecz Z, V\u00e1lyi-Nagy I. Post-acute COVID-19 syndrome. [Posztakut COVID-19 szindr\u00f3ma.] Orv Hetil. 2021; 162: 1067-1078. [Hungarian]","DOI":"10.1556\/650.2021.32282"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Gy\u0151rffy Zs, B\u00e9k\u00e1si S, Szathm\u00e1ri-M\u00e9sz\u00e1ros N, et al. Possibilities of telemedicine regarding the COVID-19 pandemic in light of the international and Hungarian experiences and recommendations. [A telemedicina lehet\u0151s\u00e9gei a COVID-19-pand\u00e9mia kapcs\u00e1n a nemzetk\u00f6zi \u00e9s a magyarorsz\u00e1gi tapasztalatok \u00e9s aj\u00e1nl\u00e1sok t\u00fckr\u00e9ben.] Orv Hetil. 2020; 161: 983-992. [Hungarian]","DOI":"10.1556\/650.2020.31873"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Vajer P, Csenteri O, Szab\u00f3 J, et al. Family medicine during COVID-19 pandemic. [H\u00e1ziorvosl\u00e1s a COVID-19-j\u00e1rv\u00e1ny idej\u00e9n.] Orv Hetil. 2020; 161: 1699-1705. [Hungarian]","DOI":"10.1556\/650.2020.31954"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5 Kar\u00e1szi \u00c9, Onoz\u00f3 B, S\u00fct\u0151 A, et al. Clinical and epidemiological characteristics of pediatric COVID-19 patients in a community-based study. [Az alapell\u00e1t\u00e1sban kezelt COVID-19-fert\u0151z\u00f6tt gyermekek t\u00fcnettani \u00e9s epidemiol\u00f3giai jellemz\u0151i.] Orv Hetil. 2021; 162: 1751-1760. [Hungarian]","DOI":"10.1556\/650.2021.32360"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.5588\/ijtld.21.0135","article-title":"Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms","volume":"25","author":"6 Mohamed-Hussein","year":"2021","unstructured":"6 Mohamed-Hussein AA, Amin MT, Makhlouf HA, et al. Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms. Int J Tuberc Lung Dis. 2021; 25: 732-737.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.dsx.2020.12.025","article-title":"Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria","volume":"15","author":"7 Raveendran","year":"2021","unstructured":"7 Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021; 15: 145-146.","journal-title":"Diabetes Metab Syndr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020","volume":"69","author":"8 Tenforde","year":"2020","unstructured":"8 Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. Morb Mortal Wkly Rep. 2020; 69: 993-998.","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmi.2020.09.052","article-title":"Follow-up of adults with noncritical COVID-19 two months after symptom onset","volume":"27","author":"9 Carvalho-Schneider","year":"2020","unstructured":"9 Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2020; 27: 258-263.","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10 Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE 2020; 15: e0240784.","DOI":"10.1371\/journal.pone.0240784"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11 Sykes DL, Holdsworth L, Jawad N, et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung 2021; 199, 113-119.","DOI":"10.1007\/s00408-021-00423-z"},{"key":"ref11","unstructured":"12 Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv 2020; 10.19.20214494 [cited 2021 Nov 29]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.10.19.20214494v2 [accessed: Nov 5, 2021]."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Buttery S, Philip KE, Williams P, et al. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res. 2021; 8: e001075.","DOI":"10.1136\/bmjresp-2021-001075"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14 Baranauskas MN, Carter SJ. Evidence for impaired chronotropic responses to and recovery from 6-minute walk test in women with post-acute COVID-19 syndrome. Exp Physiol 2021 Nov 10. . [Epub ahead of print]","DOI":"10.1113\/EP089965"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/bjsports-2021-104392","article-title":"Clinical patterns, recovery time and prolonged impact of COVID-19 illness in international athletes: the UK experience","volume":"56","author":"15 Hull","year":"2022","unstructured":"15 Hull JH, Wootten M, Moghal M, et al. Clinical patterns, recovery time and prolonged impact of COVID-19 illness in international athletes: the UK experience. Br J Sports Med. 2022; 56: 4-11.","journal-title":"Br J Sports Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/014107689108400224","article-title":"A report - chronic fatigue syndrome: guidelines for research","volume":"84","author":"16 Sharpe","year":"1991","unstructured":"16 Sharpe MC, Archard LC, Banatvala JE, et al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991; 84: 118-121.","journal-title":"J R Soc Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"17 Cortes Rivera","year":"2019","unstructured":"17 Cortes Rivera M, Mastronardi C, Silva-Aldana CT, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review. Diagnostics (Basel) 2019; 9: 91.","journal-title":"Diagnostics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/21641846.2018.1426086","article-title":"The International Collaborative on Fatigue Following Infection (COFFI)","volume":"6","author":"18 Katz","year":"2018","unstructured":"18 Katz BZ, Collin SM, Murphy G, et al. The International Collaborative on Fatigue Following Infection (COFFI). Fatigue 2018; 6: 106-121.","journal-title":"Fatigue"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1155\/1993\/414602","article-title":"Human herpesvirus 6 and chronic fatigue syndrome","volume":"4","author":"19 Eymard","year":"1993","unstructured":"19 Eymard D, Lebel F, Miller M, et al. Human herpesvirus 6 and chronic fatigue syndrome. Can J Infect Dis. 1993; 4: 199-202.","journal-title":"Can J Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"20 Carf\u00ec","year":"2020","unstructured":"20 Carf\u00ec A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603-605.","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21 Al-Ani RM, Acharya D. Prevalence of anosmia and ageusia in patients with COVID-19 at a Primary Health Center, Doha, Qatar. Indian J Otolaryngol Head Neck Surg. 2020; Aug 19: 1-7. . [Published online ahead of print]","DOI":"10.21203\/rs.3.rs-48737\/v1"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/9\/article-p335.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/9\/article-p335.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/9\/article-p335.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T09:51:54Z","timestamp":1698227514000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/9\/article-p335.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":21,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1556\/650.2022.32432","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,27]]}}}